Waclawiw, Myron A.

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine

Cardiovascular Health and Disease PreventionAngiogenesis and VEGF in Cancer

Cited by 3,423

Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation

Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine

Hemoglobin structure and functionNitric Oxide and Endothelin Effects

Cited by 1,807

Prognostic Value of Coronary Vascular Endothelial Dysfunction

Halcox, J. P. J., Schenke, W. H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M. A., Nour, K. R. A., & Quyyumi, A. A. (2002) · Circulation

Cardiovascular Health and Disease PreventionCardiac Imaging and Diagnostics

Cited by 1,385

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

Wang, W. C., Ware, R. E., Miller, S. T., Iyer, R. V., Casella, J. F., Minniti, C. P., Rana, S., Thornburg, C. D., Rogers, Z. R., Kalpatthi, R. V., et al. (2011) · The Lancet

Hemoglobinopathies and Related DisordersNeonatal Health and Biochemistry

Cited by 803

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up

Steinberg, M. H., McCarthy, W. F., Castro, O., Ballas, S. K., Armstrong, F. D., Smith, W., Ataga, K., Swerdlow, P., Kutlar, A., DeCastro, L., et al. (2010) · American Journal of Hematology

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 486

Role of circulating nitrite and S -nitrosohemoglobin in the regulation of regional blood flow in humans

Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences

Nitric Oxide and Endothelin EffectsHemoglobin structure and function

Cited by 441

Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxidedelivery

Cannon, R. O., Schechter, A. N., Panza, J. A., Ognibene, F. P., Pease-Fye, M. E., Waclawiw, M. A., Shelhamer, J. H., & Gladwin, M. T. (2001) · Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 298

N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease

Machado, R. F., Anthi, A., Steinberg, M. H., Bonds, D., Sachdev, V., Kato, G. J., Taveira-DaSilva, A. M., Ballas, S. K., Blackwelder, W., Xu, X., et al. (2006) · JAMA

Hemoglobinopathies and Related DisordersPulmonary Hypertension Research and Treatments

Cited by 197

Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects

Traba, J., Kwarteng-Siaw, M., Okoli, T. C., Li, J., Huffstutler, R. D., Bray, A., Waclawiw, M. A., Han, K., Pelletier, M., Sauve, A. A., et al. (2015) · Journal of Clinical Investigation

Inflammasome and immune disordersSirtuins and Resveratrol in Medicine

Cited by 180

Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction

Exner, D. V., Dries, D. L., Waclawiw, M. A., Shelton, B., & Domanski, M. J. (1999) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 172

Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial

MacDonald, M. R., She, L., Doenst, T., Binkley, P. F., Rouleau, J. L., Tan, R.-S., Lee, K. L., Miller, A. B., Sopko, G., Szalewska, D., et al. (2015) · European Journal of Heart Failure

Cardiac and Coronary Surgery TechniquesCardiovascular Function and Risk Factors

Cited by 24